Adacel Tdap 49281-0400
Generic: Clostridium Tetani Toxoid Antigen (formaldehyde Inactivated), Corynebacterium Diphtheriae Toxoid Antigen (formaldehyde Inactivated), Bordetella Pertussis Toxoid Antigen (glutaraldehyde Inactivated), Bordetella Pertussis Filamentous Hemagglutinin Antigen (formaldehyde Inactivated), Bordetella Pertussis Pertactin Antigen, And Bordetella Pertussis Fimbriae 2/3 Antigen
Product NDC
49281-0400- Manufacturer
- Sanofi Vaccines Us Inc.
- Dosage Form
- Injection, Suspension
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- June 10, 2005
- Listing Expires
- December 31, 2027
- Application
- BLA125111
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bordetella Pertussis Filamentous Hemagglutinin Antigen (formaldehyde Inactivated) | 5 ug/.5mL |
| Bordetella Pertussis Fimbriae 2/3 Antigen | 5 ug/.5mL |
| Bordetella Pertussis Pertactin Antigen | 3 ug/.5mL |
| Bordetella Pertussis Toxoid Antigen (glutaraldehyde Inactivated) | 2.5 ug/.5mL |
| Clostridium Tetani Toxoid Antigen (formaldehyde Inactivated) | 5 [Lf]/.5mL |
| Corynebacterium Diphtheriae Toxoid Antigen (formaldehyde Inactivated) | 2 [Lf]/.5mL |
Drug Class
Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]
Packaging Options(3)
5 VIAL in 1 PACKAGE (49281-400-05) / .5 mL in 1 VIAL (49281-400-58)
10 VIAL in 1 PACKAGE (49281-400-10) / .5 mL in 1 VIAL (49281-400-58)
5 SYRINGE in 1 PACKAGE (49281-400-20) / .5 mL in 1 SYRINGE (49281-400-89)
External Resources